Detalhe da pesquisa
1.
Efficacy and safety of ruxolitinib in patients with newly-diagnosed polycythemia vera: futility analysis of the RuxoBEAT clinical trial of the GSG-MPN study group.
Ann Hematol
; 102(2): 349-358, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36564535
2.
Step-in dosing of bosutinib in pts with chronic phase chronic myeloid leukemia (CML) after second-generation tyrosine kinase inhibitor (TKI) therapy: results of the Bosutinib Dose Optimization (BODO) Study.
Ann Hematol
; 102(10): 2741-2752, 2023 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-37592092
3.
Addendum to the German Consensus Recommendations on Ponatinib in the Treatment of Chronic Myeloid Leukemia.
Acta Haematol
; : 1-8, 2023 Oct 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37848002
4.
Efficacy of UVC-treated, pathogen-reduced platelets versus untreated platelets: a randomized controlled non-inferiority trial.
Haematologica
; 106(4): 1086-1096, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33538149
5.
Jak2V617F and Dnmt3a loss cooperate to induce myelofibrosis through activated enhancer-driven inflammation.
Blood
; 132(26): 2707-2721, 2018 12 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-30366920
6.
Ponatinib in the Treatment of Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Leukemia: Recommendations of a German Expert Consensus Panel with Focus on Cardiovascular Management.
Acta Haematol
; 143(3): 217-231, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31590170
7.
Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV.
Haematologica
; 104(5): 955-962, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30514803
8.
Associations between gender, disease features and symptom burden in patients with myeloproliferative neoplasms: an analysis by the MPN QOL International Working Group.
Haematologica
; 102(1): 85-93, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27540137
9.
Impact of unbalanced minor route versus major route karyotypes at diagnosis on prognosis of CML.
Ann Hematol
; 94(12): 2015-24, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26385387
10.
Inactivation of polycomb repressive complex 2 components in myeloproliferative and myelodysplastic/myeloproliferative neoplasms.
Blood
; 119(5): 1208-13, 2012 Feb 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-22053108
11.
JAK2V617F homozygosity arises commonly and recurrently in PV and ET, but PV is characterized by expansion of a dominant homozygous subclone.
Blood
; 120(13): 2704-7, 2012 Sep 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-22898600
12.
Distinct characteristics of e13a2 versus e14a2 BCR-ABL1 driven chronic myeloid leukemia under first-line therapy with imatinib.
Haematologica
; 99(9): 1441-7, 2014 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-24837466
13.
Younger patients with chronic myeloid leukemia do well in spite of poor prognostic indicators: results from the randomized CML study IV.
Ann Hematol
; 93(1): 71-80, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24162333
14.
Abelson tyrosine kinase controls phagosomal acidification required for killing of Mycobacterium tuberculosis in human macrophages.
J Immunol
; 189(8): 4069-78, 2012 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22988030
15.
Impact of additional cytogenetic aberrations at diagnosis on prognosis of CML: long-term observation of 1151 patients from the randomized CML Study IV.
Blood
; 118(26): 6760-8, 2011 Dec 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-22039253
16.
STAT1 activation in association with JAK2 exon 12 mutations.
Haematologica
; 101(1): e15-9, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26635038
17.
A review of hydroxyurea-related cutaneous adverse events.
Expert Opin Drug Saf
; 20(12): 1515-1521, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34181494
18.
Kidney Dysfunction Is Associated with Thrombosis and Disease Severity in Myeloproliferative Neoplasms: Implications from the German Study Group for MPN Bioregistry.
Cancers (Basel)
; 13(16)2021 Aug 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34439237
19.
High-resolution single-nucleotide polymorphism array-profiling in myeloproliferative neoplasms identifies novel genomic aberrations.
Haematologica
; 95(4): 666-9, 2010 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-20015882
20.
Molecular mechanisms associated with leukemic transformation of MPL-mutant myeloproliferative neoplasms.
Haematologica
; 95(12): 2153-6, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-20823136